Last Chance To Submit Abstract For 2015 Advances In Inflammatory Bowel Diseases Conference
Deadline for submission is September 15, 2015
NEW YORK, Sept. 4, 2015 /PRNewswire-USNewswire/ -- Abstracts are being accepted for the 2015 Advances in Inflammatory Bowel Diseases (AIBD), the Crohn's & Colitis Foundation of America's (CCFA) Clinical Research Conference, until September 15, 2015. AIBD, taking place at the Hilton Orlando in Orlando, Florida from December 10-12, is the only conference exclusively for gastroenterologists, pediatric specialists, clinical researchers, nurses, and other healthcare professionals with an interest in the treatment of pediatric and adult patients with inflammatory bowel diseases (IBD).The conference offers workshops, a four-track format designed for clinicians, researchers, allied health professionals, nurses and pediatric gastroenterologists.
To submit an abstract for review, visit http://owpm.net/abstracts/IBD/.
Abstracts are being accepted in the following categories: Clinical, Pediatric, Basic Science or Nursing. Abstracts are subject to acceptance by the Scientific Abstract Review Committee. Abstracts selected for presentation will be published in Inflammatory Bowel Diseases journal, February 2016 Supplement, and scheduled for oral or poster presentation. Acceptance notifications will be sent on October 16, 2015.
AIBD is endorsed by American College of Gastroenterology (ACG), American Gastroenterological Association (AGA), North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN), and the British Society of Gastroenterology (BSG), and provides continuing medical education for physicians, nurses, and physician assistants.
About Crohn's Disease and Ulcerative Colitis
Known collectively as inflammatory bowel diseases (IBD), Crohn's disease and ulcerative colitis affects 1 in 200 people. They are painful, medically incurable diseases that attack the digestive system. Crohn's disease may attack anywhere along the digestive tract, while ulcerative colitis inflames only the large intestine (colon). Symptoms may include abdominal pain, persistent diarrhea, rectal bleeding, fever and weight loss. Many patients require numerous hospitalizations and surgery. Most people develop the diseases between the ages of 15 and 35; however the incidence is increasing in children.
About CCFA
The Crohn's & Colitis Foundation of America (CCFA) is the largest non-profit voluntary health agency dedicated to finding cures for Inflammatory Bowel Diseases (IBD). CCFA's mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults who suffer from these diseases. The Foundation works to fulfill its mission by funding research, providing educational resources for patients and their families, medical professionals, and the public, and furnishing supportive services for those afflicted with IBD. For more information, visit www.ccfa.org, call 888-694-8872, like us on Facebook, find us on LinkedIn or follow us on Twitter.
CONTACT: Rebecca Kaplan, 646-943-7415, [email protected]
SOURCE Crohn's & Colitis Foundation of America
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article